Interactions Calculated between Medications and Enteral Nutrition Using an Updated Protocol in an Elderly Population in the Intensive Care Unit of a University Hospital in Central Brazil
Eriadny Laiana Nogueira Leite, Daniele Furtado Albanezi, Karuppusamy Arunachalam, Ruberlei Godinho de Oliveira
Journal of Advances in Medicine and Medical Research · pp. 122–134 · Published 1 Sep 2024
10.9734/jammr/2024/v36i95562Abstract
Introduction: Drug-nutrient interactions refer to alterations in the pharmacodynamics or pharmacokinetics of a drug due to interactions with physical, chemical, physiological, or pathophysiological factors related to nutrients. Objective: To investigate potential drug-nutrient interactions in patients receiving enteral nutrition admitted to an intensive care unit (ICU). Methods: This observational, descriptive, retrospective study employed non-probabilistic sampling of elderly patients at a university hospital in Brazil's Central Region. Potential drug-nutrient interactions were identified using the Up To Date® database, with interactions classified by risk level. Results: The study included data from 50 elderly patients, predominantly male (58%), with an average age of 70.6 ± 8.63 years. A total of 75 medications administered via the digestive tract were analyzed, of which 26 (34.66%) were found to have potential interactions according to Up To Date®, resulting in 47 types of pharmacokinetic interactions. Most interactions involved either the food/nutrient reducing the therapeutic effect of the drug or the drug lowering the serum level of the nutrient, accounting for 24 (51.06%) of the interactions. The average number of interactions was higher in deceased patients (1.5 ± 1.64) compared to those who were discharged (1.19 ± 1.44). Statistical analysis using the t-test (95% bilateral confidence interval) showed no significant difference between the groups (p-value > 0.99). Conclusion: The findings highlight the importance of monitoring drug-nutrient interactions in ICU patients, as these interactions can potentially have adverse effects on patient outcomes.
Cited by 0
No indexed citations yet.
Related research
- Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse Drug Events — shares topic coverage
- Adverse Drug Reactions and Pharmacovigilance: A Narrative Mini-review of Relevant Literature — shares topic coverage
- Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process — shares topic coverage
- Evaluation of the Renal Safety of Direct Acting Antivirals in Chronic Hepatitis C Patients — shares topic coverage
- Assessment of Hospital Physicians' Knowledge, Awareness, Attitude and Practice of Reporting Adverse Drug Reactions in Jeddah, Saudi Arabia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.